Oxygen therapy, also known as supplemental oxygen, is the use of oxygen as a medical treatment. This can include for low blood oxygen, carbon monoxide toxicity, cluster headaches, and to maintain enough oxygen while inhaled anesthetics are given. Long term oxygen is often useful in people with chronically low oxygen such as from severe COPD or cystic fibrosis. Oxygen can be given in a number of ways including nasal cannula, face mask, and inside a hyperbaric chamber.
A person wearing a simple face mask
|Synonyms||supplemental oxygen, enriched air|
|AHFS/Drugs.com||FDA Professional Drug Information|
|Drug class||medical gas|
|Chemical and physical data|
Oxygen is required for normal cell metabolism. Excessively high concentrations can cause oxygen toxicity such as lung damage or result in respiratory failure in those who are predisposed. Higher oxygen concentrations also increase the risk of fires, particularly while smoking, and without humidification can also dry out the nose. The target oxygen saturation recommended depends on the condition being treated. In most conditions a saturation of 94–98% is recommended, while in those at risk of carbon dioxide retention saturations of 88–92% are preferred, and in those with carbon monoxide toxicity or cardiac arrest they should be as high as possible. Air is typically 21% oxygen by volume while oxygen therapy increases this by some amount up to 100%.
The use of oxygen in medicine became common around 1917. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The cost of home oxygen is about 150 USD a month in Brazil and 400 USD a month in the United States. Home oxygen can be provided either by oxygen tanks or an oxygen concentrator. Oxygen is believed to be the most common treatment given in hospitals in the developed world.
Oxygen is used as a medical treatment in both chronic and acute cases, and can be used in hospital, pre-hospital or entirely out of hospital, dependent on the needs of the patient and their medical professionals' opinions.
A common use of supplementary oxygen is in patients with chronic obstructive pulmonary disease (COPD), the occurrence of chronic bronchitis or emphysema, a common long-term effect of smoking, who may require additional oxygen to breathe either during a temporary worsening of their condition, or throughout the day and night. It is indicated in COPD patients with arterial oxygen partial pressure PaO
2 ≤ 55 mmHg (7.3 kPa) or arterial oxygen saturation SaO
2 ≤ 88% and has been shown to increase lifespan.
Oxygen is often prescribed for people with breathlessness, in the setting of end-stage cardiac or respiratory failure, advanced cancer or neurodegenerative disease, despite having relatively normal blood oxygen levels. A 2010 trial of 239 subjects found no significant difference in reducing breathlessness between oxygen and air delivered in the same way.
It may also be indicated for any other patient where their injury or illness has caused hypoxaemia, although in this case oxygen flow should be moderated to achieve target oxygen saturation levels, based on pulse oximetry (with a target level of 94–98% in most patients, or 88–92% in COPD patients).
Patients who are receiving oxygen therapy for hypoxemia following an acute illness or hospitalization should not routinely have a prescription renewal for continued oxygen therapy without a physician's re-assessment of the patient's condition. If the person has recovered from the illness, then the hypoxemia is expected to resolve and additional care would be unnecessary and a waste of resources.
Many EMS protocols indicate that oxygen should not be withheld from any patient, while other protocols are more specific or circumspect. However, there are certain situations in which oxygen therapy is known to have a negative impact on a patient’s condition.
Oxygen should never be given to a patient who is suffering from paraquat poisoning unless they are suffering from severe respiratory distress or respiratory arrest, as this can increase the toxicity. (Paraquat poisoning is rare — for example 200 deaths globally from 1958 to 1978). Oxygen therapy is not recommended for patients who have suffered pulmonary fibrosis or other lung damage resulting from bleomycin treatment.
High levels of oxygen given to infants causes blindness by promoting overgrowth of new blood vessels in the eye obstructing sight. This is retinopathy of prematurity (ROP).
Oxygen has vasoconstrictive effects on the circulatory system, reducing peripheral circulation and was once thought to potentially increase the effects of stroke. However, when additional oxygen is given to the patient, additional oxygen is dissolved in the plasma according to Henry's Law. This allows a compensating change to occur and the dissolved oxygen in plasma supports embarrassed (oxygen-starved) neurons, reduces inflammation and post-stroke cerebral edema. Since 1990, hyperbaric oxygen therapy has been used in the treatments of stroke on a worldwide basis. In rare instances, hyperbaric oxygen therapy patients have had seizures. However, because of the aforementioned Henry's Law effect of extra available dissolved oxygen to neurons, there is usually no negative sequel to the event. Such seizures are generally a result of oxygen toxicity, although hypoglycemia may be a contributing factor, but the latter risk can be eradicated or reduced by carefully monitoring the patient's nutritional intake prior to oxygen treatment.
Oxygen first aid has been used as an emergency treatment for diving injuries for years. Recompression in a hyperbaric chamber with the patient breathing 100% oxygen is the standard hospital and military medical response to decompression illness. The success of recompression therapy as well as a decrease in the number of recompression treatments required has been shown if first aid oxygen is given within four hours after surfacing. There are suggestions that oxygen administration may not be the most effective measure for the treatment of decompression illness and that heliox may be a better alternative.
Chronic obstructive pulmonary diseaseEdit
Care needs to be exercised in patients with chronic obstructive pulmonary disease, such as emphysema, especially in those known to retain carbon dioxide (type II respiratory failure). Such patients may further accumulate carbon dioxide and decreased pH (hypercapnation) if administered supplemental oxygen, possibly endangering their lives. This is primarily as a result of ventilation–perfusion imbalance (see Effect of oxygen on chronic obstructive pulmonary disease). In the worst case, administration of high levels of oxygen in patients with severe emphysema and high blood carbon dioxide may reduce respiratory drive to the point of precipitating respiratory failure, with an observed increase in mortality compared with those receiving titrated oxygen treatment. However, the risk of the loss of respiratory drive are far outweighed by the risks of withholding emergency oxygen, and therefore emergency administration of oxygen is never contraindicated. Transfer from field care to definitive care, where oxygen use can be carefully calibrated, typically occurs long before significant reductions to the respiratory drive.
A 2010 study has shown that titrated oxygen therapy (controlled administration of oxygen) is less of a danger to COPD patients and that other, non-COPD patients, may also, in some cases, benefit more from titrated therapy.
Highly concentrated sources of oxygen promote rapid combustion. Oxygen itself is not flammable, but the addition of concentrated oxygen to a fire greatly increases its intensity, and can aid the combustion of materials (such as metals) which are relatively inert under normal conditions. Fire and explosion hazards exist when concentrated oxidants and fuels are brought into close proximity; however, an ignition event, such as heat or a spark, is needed to trigger combustion. A well-known example of an accidental fire accelerated by pure oxygen occurred in the Apollo 1 spacecraft in January 1967 during a ground test; it killed all three astronauts. A similar accident killed Soviet cosmonaut Valentin Bondarenko in 1961.
Combustion hazards also apply to compounds of oxygen with a high oxidative potential, such as peroxides, chlorates, nitrates, perchlorates, and dichromates because they can donate oxygen to a fire.[relevant? ]
2 will allow combustion to proceed rapidly and energetically. Steel pipes and storage vessels used to store and transmit both gaseous and liquid oxygen will act as a fuel; and therefore the design and manufacture of O
2 systems requires special training to ensure that ignition sources are minimized. Highly concentrated oxygen in a high-pressure environment can spontaneously ignite hydrocarbons such as oil and grease, resulting in fire or explosion. The heat caused by rapid pressurization serves as the ignition source. For this reason, storage vessels, regulators, piping and any other equipment used with highly concentrated oxygen must be "oxygen-clean" prior to use, to ensure the absence of potential fuels. This does not apply only to pure oxygen; any concentration significantly higher than atmospheric (approximately 21%) carries a potential risk.
Hospitals in some jurisdictions, such as the UK, now operate "no-smoking" policies, which although introduced for other reasons, support the aim of keeping ignition sources away from medical piped oxygen. Recorded sources of ignition of medically prescribed oxygen include candles, aromatherapy, medical equipment, cooking, and unfortunately, deliberate vandalism. Smoking of pipes, cigars and cigarettes is of special concern. These policies do not entirely eliminate the risk of injury with portable oxygen systems, especially if compliance is poor.
Some practitioners of alternative medicine have promoted "oxygen therapy" as a cure for many human ailments including AIDS, Alzheimer's disease and cancer. The procedure may include injecting hydrogen peroxide, oxygenating blood, or administering oxygen under pressure to the rectum, vagina, or other bodily opening. According to the American Cancer Society, "available scientific evidence does not support claims that putting oxygen-releasing chemicals into a person's body is effective in treating cancer", and some of these treatments can be dangerous.
Storage and sourcesEdit
Oxygen can be separated by a number of methods, including chemical reaction and fractional distillation, and then either used immediately or stored for future use. The main types of sources for oxygen therapy are:
- Liquid storage — Liquid oxygen is stored in chilled tanks until required, and then allowed to boil (at a temperature of 90.188 K (−182.96 °C)) to release oxygen as a gas. This is widely used at hospitals due to their high usage requirements, but can also be used in other settings. See Vacuum Insulated Evaporator for more information on this method of storage.
- Compressed gas storage — The oxygen gas is compressed in a gas cylinder, which provides a convenient storage, without the requirement for refrigeration found with liquid storage. Large oxygen cylinders hold 6,500 litres (230 cu ft) and can last about two days at a flow rate of 2 litres per minute. A small portable M6 (B) cylinder holds 164 or 170 litres (5.8 or 6.0 cu ft) and weighs about 1.3 to 1.6 kilograms (2.9 to 3.5 lb). These tanks can last 4–6 hours when used with a conserving regulator, which senses the patient's breathing rate and sends pulses of oxygen. Conserving regulators may not be usable by patients who breathe through their mouths.
- Instant usage — The use of an electrically powered oxygen concentrator or a chemical reaction based unit can create sufficient oxygen for a patient to use immediately, and these units (especially the electrically powered versions) are in widespread usage for home oxygen therapy and portable personal oxygen, with the advantage of being continuous supply without the need for additional deliveries of bulky cylinders.
Various devices are used for administration of oxygen. In most cases, the oxygen will first pass through a pressure regulator, used to control the high pressure of oxygen delivered from a cylinder (or other source) to a lower pressure. This lower pressure is then controlled by a flowmeter, which may be preset or selectable, and this controls the flow in a measure such as litres per minute (lpm). The typical flowmeter range for medical oxygen is between 0 and 15 lpm with some units able to obtain up to 25 liters per minute. Many wall flowmeters using a Thorpe tube design are able to be dialed to "flush" which is beneficial in emergency situations.
Many people only require a slight increase in oxygen in the air they breathe, rather than pure or near-pure oxygen. This can be delivered through a number of devices dependent on the situation, the flow required and in some instances patient preference.
A nasal cannula (NC) is a thin tube with two small nozzles that protrude into the patient's nostrils. It can only comfortably provide oxygen at low flow rates, 2–6 litres per minute (LPM), delivering a concentration of 24–40%.
There are also a number of face mask options, such as the simple face mask, often used at between 5 and 8 LPM, with a concentration of oxygen to the patient of between 28% and 50%. This is closely related to the more controlled air-entrainment masks, also known as Venturi masks, which can accurately deliver a predetermined oxygen concentration to the trachea up to 40%.
In some instances, a partial rebreathing mask can be used, which is based on a simple mask, but featuring a reservoir bag, which increases the provided oxygen concentration to 40–70% oxygen at 5–15 LPM.
Non-rebreather masks draw oxygen from attached reservoir bags, with one-way valves that direct exhaled air out of the mask. When properly fitted and used at flow rates of 8–10 LPM or higher, they deliver close to 100% oxygen. This type of mask is indicated for acute medical emergencies.
Demand oxygen delivery systems (DODS) or oxygen resuscitators deliver oxygen only when the person inhales, or, in the case of a non-breathing person, the caregiver presses a button on the mask. These systems greatly conserve oxygen compared to steady-flow masks, which is useful in emergency situations when a limited supply of oxygen is available and there is a delay in transporting the patient to higher care. They are very useful in performing CPR, as the caregiver can deliver rescue breaths composed of 100% oxygen with the press of a button. Care must be taken not to over-inflate the patient's lungs, and some systems employ safety valves to help prevent this. These systems may not be appropriate for unconscious patients or those in respiratory distress, because of the effort required to breathe from them.
High flow oxygen deliveryEdit
In cases where the patient requires a high concentration of up to 100% oxygen, a number of devices are available, with the most common being the non-rebreather mask (or reservoir mask), which is similar to the partial rebreathing mask except it has a series of one-way valves preventing exhaled air from returning to the bag. There should be a minimum flow of 10 L/min. The delivered FIO2 (Inhalation volumetric fraction of molecular oxygen) of this system is 60–80%, depending on the oxygen flow and breathing pattern. Another type of device is a humidified high flow nasal cannula which enables flows exceeding a patient's peak inspiratory flow demand to be delivered via nasal cannula, thus providing FIO2 of up to 100% because there is no entrainment of room air, even with the mouth open. This also allows the patient to continue to talk, eat and drink while still receiving the therapy. This type of delivery method is associated with greater overall comfort, and improved oxygenation and respiratory rates than with face mask oxygen.
Positive pressure deliveryEdit
Patients who are unable to breathe on their own will require positive pressure to move oxygen into their lungs for gaseous exchange to take place. Systems for delivering this vary in complexity (and cost), starting with a basic pocket mask adjunct which can be used by a basically trained first aider to manually deliver artificial respiration with supplemental oxygen delivered through a port in the mask.
Many emergency medical service and first aid personnel, as well as hospitals, will use a bag-valve-mask (BVM), which is a malleable bag attached to a face mask (or invasive airway such as an endotracheal tube or laryngeal mask airway), usually with a reservoir bag attached, which is manually manipulated by the healthcare professional to push oxygen (or air) into the lungs. This is the only procedure allowed for initial treatment of cyanide poisoning in the UK workplace.
Automated versions of the BVM system, known as a resuscitator or pneupac can also deliver measured and timed doses of oxygen direct to patient through a facemask or airway. These systems are related to the anaesthetic machines used in operations under general anaesthesia that allows a variable amount of oxygen to be delivered, along with other gases including air, nitrous oxide and inhalational anaesthetics.
As a drug delivery routeEdit
Oxygen and other compressed gasses are used in conjunction with a nebulizer to allow the delivery of medications to the upper and/or lower airways. Nebulizers use compressed gas to propel liquid medication into an aerosol, with specific therapeutically sized droplets, for deposition in the appropriate, desired portion of the airway. A typical compressed gas flow rate of 8–10 L/min is used to nebulize medications, saline, sterile water, or a mixture of the preceding into a therapeutic aerosol for inhalation. In the clinical setting room air (ambient mix of several gasses), molecular oxygen, and Heliox are the most common gases used to nebulize a bolus or a continuous volume of therapeutic aerosols.
Exhalation filters for oxygen masksEdit
Filtered oxygen masks have the ability to prevent exhaled, potentially infectious particles from being released into the surrounding environment. These masks are normally of a closed design such that leaks are minimized and breathing of room air is controlled through a series of one-way valves. Filtration of exhaled breaths is accomplished either by placing a filter on the exhalation port, or through an integral filter that is part of the mask itself. These masks first became popular in the Toronto (Canada) healthcare community during the 2003 SARS Crisis. SARS was identified as being respiratory based and it was determined that conventional oxygen therapy devices were not designed for the containment of exhaled particles. Common practices of having suspected patients[clarification needed] wear a surgical mask was confounded by the use of standard oxygen therapy equipment. In 2003, the HiOx80 oxygen mask was released for sale. The HiOx80 mask is a closed design mask that allows a filter to be placed on the exhalation port. Several new designs have emerged in the global healthcare community for the containment and filtration of potentially infectious particles. Other designs include the ISO-O
2 oxygen mask, the Flo2Max oxygen mask, and the O-Mask. The use of oxygen masks that are capable of filtering exhaled particles is gradually becoming a recommended practice for pandemic preparation in many jurisdictions.
Typical oxygen masks allow the patient to breathe in room air in addition to their therapeutic oxygen, but because filtered oxygen masks use a closed design that minimizes or eliminates the patient's contact with and ability to inhale room air, delivered oxygen concentrations to the patient have been found to be higher, approaching 99% using adequate oxygen flows. Because all exhaled particles are contained within the mask, nebulized medications are also prevented from being released into the surrounding atmosphere, decreasing the occupational exposure to healthcare staff and other patients.
In the United States, most airlines restrict the devices allowed on board aircraft. As a result, passengers are restricted in what devices they can use. Some airlines will provide cylinders for passengers with an associated fee. Other airlines allow passengers to carry on approved portable concentrators. However the lists of approved devices varies by airline so passengers need to check with any airline they are planning to fly on. Passengers are generally not allowed to carry on their own cylinders. In all cases, passengers need to notify the airline in advance of their equipment.
Effective May 13, 2009, the Department of Transportation and FAA ruled that a select number of portable oxygen concentrators are approved for use on all commercial flights. FAA regulations require larger airplanes to carry D-cylinders of oxygen for use in an emergency.
- British national formulary : BNF 69 (69 ed.). British Medical Association. 2015. pp. 217–218, 302. ISBN 9780857111562.
- WHO Model Formulary 2008 (PDF). World Health Organization. 2009. p. 20. ISBN 9789241547659. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.
- Jamison, Dean T.; Breman, Joel G.; Measham, Anthony R.; Alleyne, George; Claeson, Mariam; Evans, David B.; Jha, Prabhat; Mills, Anne; Musgrove, Philip (2006). Disease Control Priorities in Developing Countries. World Bank Publications. p. 689. ISBN 9780821361801. Archived from the original on 2017-05-10.
- Macintosh, Michael; Moore, Tracey (1999). Caring for the Seriously Ill Patient 2E (2 ed.). CRC Press. p. 57. ISBN 9780340705827. Archived from the original on 2017-01-18.
- Dart, Richard C. (2004). Medical Toxicology. Lippincott Williams & Wilkins. pp. 217–219. ISBN 9780781728454. Archived from the original on 2017-01-18.
- Peate, Ian; Wild, Karen; Nair, Muralitharan (2014). Nursing Practice: Knowledge and Care. John Wiley & Sons. p. 572. ISBN 9781118481363. Archived from the original on 2017-01-18.
- Martin, Lawrence (1997). Scuba Diving Explained: Questions and Answers on Physiology and Medical Aspects of Scuba Diving. Lawrence Martin. p. H-1. ISBN 9780941332569. Archived from the original on 2017-01-18.
- Agasti, T. K. (2010). Textbook of Anesthesia for Postgraduates. JP Medical Ltd. p. 398. ISBN 9789380704944. Archived from the original on 2017-05-10.
- Rushman, Geoffrey B.; Davies, N. J. H.; Atkinson, Richard Stuart (1996). A Short History of Anaesthesia: The First 150 Years. Butterworth-Heinemann. p. 39. ISBN 9780750630665. Archived from the original on 2017-05-10.
- "WHO Model List of Essential Medicines (19th List)" (PDF). World Health Organization. April 2015. Archived (PDF) from the original on 13 December 2016. Retrieved 8 December 2016.
- Wyatt, Jonathan P.; Illingworth, Robin N.; Graham, Colin A.; Hogg, Kerstin; Robertson, Colin; Clancy, Michael (2012). Oxford Handbook of Emergency Medicine. OUP Oxford. p. 95. ISBN 9780191016059. Archived from the original on 2017-01-18.
- McDonald, Christine F; Crockett, Alan J; Young, Iven H (2005). "Adult domicilariary oxygen. Position statement of the Thoracic Society of Australia and New Zealand". The Medical Journal of Australia. 182 (12): 621–6. Archived from the original on 2006-06-14.
- Stoller, JK.; Panos, RJ.; Krachman, S.; Doherty, DE.; Make, B. (Jul 2010). "Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial". Chest. 138 (1): 179–87. doi:10.1378/chest.09-2555. PMC . PMID 20605816.
- "Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group". Ann Intern Med. 93 (3): 391–8. Sep 1980. doi:10.7326/0003-4819-93-3-391. PMID 6776858.
- Abernethy, Amy P.; McDonald, Christine F.; Frith, Peter A.; Clark, Katherine; Herndon, James E., II; Marcello, Jennifer; Young, Iven H.; Bull, Janet; Wilcock, Andrew; Booth, Sara; Wheeler, Jane L.; Tulsky, James A.; Crockett, Alan J.; Currow, David C. (4 September 2010). "Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial". Lancet. 376 (9743): 784–793. doi:10.1016/S0140-6736(10)61115-4. PMC . PMID 20816546.
- "Clinical Guidelines Update — Oxygen" (PDF). Joint Royal Colleges Ambulance Liaison Committee/Warwick University. April 2009. Archived (PDF) from the original on 2009-07-11. Retrieved 2009-06-29.
- O'Driscoll BR, Howard LS, Davison AG (October 2008). "BTS guideline for emergency oxygen use in adult patients". Thorax. British Thoracic Society. 63 (Suppl 6:vi): 1–68. doi:10.1136/thx.2008.102947. PMID 18838559. Archived from the original (PDF) on 2015-04-13.
- Sands, George. "Oxygen Therapy for Headaches". Archived from the original on 2007-12-01. Retrieved 2007-11-26.
- American College of Chest Physicians; American Thoracic Society (September 2013), "Five Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, American College of Chest Physicians and American Thoracic Society, archived from the original on 2013-11-03, retrieved 2013-01-06, which cites
- Croxton, T. L.; Bailey, W. C.; for the NHLBI Working Group on Long-term Oxygen Treatment in COPD (2006). "Long-term Oxygen Treatment in Chronic Obstructive Pulmonary Disease: Recommendations for Future Research". American Journal of Respiratory and Critical Care Medicine. 174 (4): 373–378. doi:10.1164/rccm.200507-1161WS. PMC . PMID 16614349.
- O'Driscoll, B. R.; Howard, L. S.; Davison, A. G.; British Thoracic, S. (2008). "BTS guideline for emergency oxygen use in adult patients". Thorax. 63: vi1–v68. doi:10.1136/thx.2008.102947. PMID 18838559.
- MacNee, W. (2005). "Prescription of Oxygen". American Journal of Respiratory and Critical Care Medicine. 172 (5): 517–518. doi:10.1164/rccm.2506007. PMID 16120712.
- Patarinski, D (1976). "Indications and contraindications for oxygen therapy of respiratory insufficiency". Vŭtreshni bolesti (in Bulgarian and English). 15 (4): 44–50. PMID 1007238.
- Experience with paraquat poisoning in a respiratory intensive care unit in North India
- "EMT Medication Formulary" (PDF). PHECC Clinical Practice Guidelines. Pre-Hospital Emergency Care Council. 15 July 2009. p. 84. Archived from the original (PDF) on 14 May 2011. Retrieved 2010-04-14.
- Smerz, R.W. (2004). "Incidence of oxygen toxicity during the treatment of dysbarism". Undersea and Hyperbaric Medicine. 31 (2): 199–202. PMID 15485081. Archived from the original on 2011-05-13. Retrieved 2008-04-30.
- Hampson, Neal B.; Simonson, Steven G.; Kramer, C.C.; Piantadosi, Claude A. (1996). "Central nervous system oxygen toxicity during hyperbaric treatment of patients with carbon monoxide poisoning". Undersea and Hyperbaric Medicine. 23 (4): 215–9. PMID 8989851. Archived from the original on 2011-05-14. Retrieved 2008-04-29.
- Brubakk, A. O.; T. S. Neuman (2003). Bennett and Elliott's physiology and medicine of diving (5th Rev ed.). United States: Saunders Ltd. p. 800. ISBN 0-7020-2571-2.
- Undersea and Hyperbaric Medical Society. "Decompression Sickness or Illness and Arterial Gas Embolism". Archived from the original on 2008-07-05. Retrieved 2008-05-30.
- Acott, C. (1999). "A brief history of diving and decompression illness". South Pacific Underwater Medicine Society Journal. 29 (2). ISSN 0813-1988. OCLC 16986801. Archived from the original on 2009-02-01. Retrieved 2008-05-30.
- Longphre, J. M.; P. J. DeNoble; R. E. Moon; R. D. Vann; J. J. Freiberger (2007). "First aid normobaric oxygen for the treatment of recreational diving injuries". Undersea Hyperb. Med. 34 (1): 43–49. ISSN 1066-2936. OCLC 26915585. PMID 17393938. Archived from the original on 2008-06-13. Retrieved 2008-05-30.
- Kol S, Adir Y, Gordon CR, Melamed Y (June 1993). "Oxy-helium treatment of severe spinal decompression sickness after air diving". Undersea Hyperb Med. 20 (2): 147–54. PMID 8329941. Archived from the original on 2009-02-01. Retrieved 2008-05-30.
- Austin, Michael A; Wills, Karen E; Blizzard, Leigh; Walters, Eugene H; Wood-Baker, Richard (18 October 2010). "Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial". British Medical Journal. 341 (oct18 2): c5462. doi:10.1136/bmj.c5462. ISSN 0959-8138. PMC . PMID 20959284. Archived from the original on 26 October 2010.
- Kim, Victor; Benditt, Joshua O; Wise, Robert A; Sharafkhaneh, Amir (2008). "Oxygen therapy in chronic obstructive pulmonary disease". Proceedings of the American Thoracic Society. 5 (4): 513–8. doi:10.1513/pats.200708-124ET. PMC . PMID 18453364.
- Werley, Barry L. (Edtr.) (1991). "Fire Hazards in Oxygen Systems". ASTM Technical Professional training. Philadelphia: ASTM International Subcommittee G-4.05.
- Orloff, Richard W. (September 2004) [First published 2000]. "Apollo 1 – The Fire: 27 January 1967". Apollo by the Numbers: A Statistical Reference. NASA History Division, Office of Policy and Plans. NASA History Series. Washington, D.C.: NASA. ISBN 0-16-050631-X. LCCN 00061677. NASA SP-2000-4029. Archived from the original on 6 June 2013. Retrieved 22 July 2017.
- Lindford AJ, Tehrani H, Sassoon EM, O'Neill TJ (June 2006). "Home Oxygen Therapy and Cigarette Smoking: A Dangerous Practice". Annals of Burns and Fire Disasters. 19 (2). Archived from the original on 2008-11-21.
- "Oxygen Therapy". American Cancer Society. 26 December 2012. Archived from the original on 21 March 2012. Retrieved 2013-09-20.
- "Luxfer Aluminum Oxygen Cylinders". CPR Savers & First Aid Supply. Archived from the original on 2010-04-18. Retrieved 2010-04-18.
- McCoy, Robert. "Portable Oxygen Concentrators (POC) Performance Variables that Affect Therapy" (PDF). Archived from the original (pdf) on 2007-07-09. Retrieved 2007-07-03.
- Evaluation of the System O2 Inc. Portable Nonpressurized Oxygen Delivery System[permanent dead link]
- Kallstrom 2002
- Garcia JA, Gardner D, Vines D, Shelledy D, Wettstein R, Peters J (October 2005). "The Oxygen Concentrations Delivered by Different Oxygen Therapy Systems". Chest Meeting. 128 (4): 389S–390S. doi:10.1378/chest.128.4_meetingabstracts.389s-b.[permanent dead link]
- Earl, John. Delivery of High FiO
2. Cardinal Health Respiratory Abstracts.
- Accurate Oxygen Delivery Archived 2013-04-03 at the Wayback Machine.
- Sim, DA; Dean, P; Kinsella, J; Black, R; Carter, R; Hughes, M (September 2008). "Performance of oxygen delivery devices when the breathing pattern of respiratory failure is simulated". Anaesthesia. 63 (9): 938–40. doi:10.1111/j.1365-2044.2008.05536.x. PMID 18540928.
- Roca O, Riera J, Torres F, Masclans JR (April 2010). "High-flow oxygen therapy in acute respiratory failure". Respiratory Care. 55 (4): 408–13. PMID 20406507. Archived from the original on 2013-05-11.
- Cyanide poisoning — New recommendations on first aid treatment Archived 2009-10-20 at the Wayback Machine.
- Hui DS, Hall SD, Chan MT, et al. (August 2007). "Exhaled air dispersion during oxygen delivery via a simple oxygen mask". Chest. 132 (2): 540–6. doi:10.1378/chest.07-0636. PMID 17573505.[permanent dead link]
- Mardimae A, Slessarev M, Han J, et al. (October 2006). "Modified N95 mask delivers high inspired oxygen concentrations while effectively filtering aerosolized microparticles". Annals of Emergency Medicine. 48 (4): 391–9, 399.e1–2. doi:10.1016/j.annemergmed.2006.06.039. PMID 16997675.
- Somogyi R, Vesely AE, Azami T, et al. (March 2004). "Dispersal of respiratory droplets with open vs closed oxygen delivery masks: implications for the transmission of severe acute respiratory syndrome". Chest. 125 (3): 1155–7. doi:10.1378/chest.125.3.1155. PMID 15006983.[permanent dead link]
- "FAA Approved Portable Oxygen Concentrators – Positive Testing Results". faa.gov. Archived from the original on 2014-07-02. Retrieved 2014-06-22.
(As of November 2014[update]) Positive Testing Results: AirSep FreeStyle, AirSep LifeStyle, AirSep Focus, AirSep Freestyle 5, (Caire) SeQual eQuinox / Oxywell (model 4000), Delphi RS-00400 / Oxus RS-00400, DeVilbiss Healthcare iGo, Inogen One, Inogen One G2, lnogen One G3, lnova Labs LifeChoice Activox, International Biophysics LifeChoice / lnova Labs LifeChoice, Invacare XPO2, Invacare Solo 2, Oxylife Independence Oxygen Concentrator, Precision Medical EasyPulse, Respironics EverGo, Respironics SimplyGo, Sequal Eclipse, SeQual SAROS, VBox Trooper
- Kallstrom, TJ (June 2002). "American Association for Respiratory Care Clinical Practice Guideline: Oxygen therapy for adults in the acute care facility—2002 Revision & Update". Respir Care. 47 (6): 717–20. PMID 12078655.
- Cahill Lambert AE (November 2005). "Adult domiciliary oxygen therapy: a patient's perspective". The Medical Journal of Australia. 183 (9): 472–3. PMID 16274348.